Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today

Benzinga19:45 ET

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

Benzinga13:55 ET

WeightWatchers Rises on Partnership With Eli Lilly to Enhance Zepbound Access

Seeking AlphaApr 29 10:02 ET

Goldman Sachs: Oral weight loss drugs will be one of the most promising new medications in recent years!

Goldman Sachs predicts that by 2030, oral weight loss drugs will account for 24% of the total weight loss drug market, and Eli Lilly and Co will lead this segment with its orforglipron. Next, pay close attention to the third-quarter results of the ATTAIN-1 trial announced by Eli Lilly, which will be the first reading of orforglipron in the field of obesity and the most important next catalyst for the oral obesity drug market.

wallstreetcnApr 28 20:47 ET

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications

BenzingaApr 28 15:50 ET

9 Health Care Stocks Whale Activity In Today's Session

BenzingaApr 28 13:35 ET